Dezocine inhibits proliferation as well as migration of endometrial carcinoma in vitro

Endometrial cancer (EC) includes several epithelial malignancies existed in the endometrium tissues. To improve the prognosis of EC, it is greatly needed to find new drugs. Dezocine, a organic compound, is an κ agonist and a µ receptor antagonist, is used in clinical anesthesia after cancer surgery with few side effects, and its anti-tumor effects have also been demonstrated in several tumors. However, the effects of Dezocine on EC progression have not been elusidated. Herein, we investigated the role of Dezocine in EC cell functions. Through a series of cellular assays, such as cell counting kit-8 (CCK-8), flow cytometry (FCM), transwell assays, we found that Dezocine suppressed the EC cell proliferation, and stimulated EC cell apoptosis in vitro. Furthermore, results revealed Dezocine restrained the motility, including migration and invasion of EC cells. Mechanically, Dezocine suppressed the Akt (protein kinase B, PKB)/mammalian target of rapamycin (mTOR) pathway in EC cells, thereby suppressing EC cell proliferation as well as migration in vitro. In conclusion, Dezocine inhibits proliferation as well as migration of EC in vitro.

Endometrial cancer (EC); Dezocine; Apoptosis; Proliferation; Akt/mTOR pathway

[1] AN HJ, SONG DH, KIM Y, JO HC, BAEK JC, PARK JE. Significance of HER2 and VEGFR2 in early-stage endometrial cancer. In Vivo. 2022; 36: 723–730.

[2] Español P, Luna R, Soler C, Caruana P, Altés-Arranz A, Rodríguez F, et al. Neural plasticity of the uterus: new targets for endometrial cancer? Women’s Health. 2022; 18: 17455057221095537.

[3] Goel P, Singh V, Sharma R, Chaudhary D, Chatterjee A, Dora T, et al. Early endometrial carcinoma: experience and outcomes. Journal of Cancer Research and Therapeutics. 2023; 19: S318–S322.

[4] Camilloni A, Nati G, Maggiolini P, Romanelli A, Latina R, Giannarelli D, et al. Chronic non-cancer pain in primary care: an Italian cross-sectional study. Signa Vitae. 2021; 17: 54–62.

[5] Pitakkarnkul S, Chanpanitkitchot S, Tangjitgamol S. Management of inoperable endometrial cancer. Obstetrics & Gynecology Science. 2022; 65: 303–316.

[6] Qiu J, Zhang Y, Xie M. Chrysotoxine attenuates sevoflurane-induced neurotoxicity in vitro via regulating PI3K/AKT/GSK pathway. Signa Vitae. 2021; 17: 185–191.

[7] Tan H, Wang C, Jiang Y, Shi Q, Liang W, Li D. Postoperative effect of sufentanil preemptive analgesia combined with psychological intervention on breast cancer patients. BMC Anesthesiology. 2023; 23: 170.

[8] Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Annals of Surgical Oncology. 2015; 22: 1341–1348.

[9] Zhang C, Pan R, Ma S, Xu S, Wang B. Dezocine inhibits cell proliferation, migration, and invasion by targeting CRABP2 in ovarian cancer. Open Medicine. 2022; 17: 2052–2061.

[10] Wang H, Chiang C, Xue C, Zhou L, Li S, Zhou Y, et al. Dezocine induces apoptosis in human cervical carcinoma Hela cells via the endoplasmic reticulum stress pathway. Toxicology Research. 2022; 11: 498–510.

[11] Li J, Zhang C, Jiang H, Cheng J. Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth. OncoTargets and Therapy. 2015; 8: 427–435.

[12] Saldaña-Inda I, Tejada-Meza H, Sainz-Pardo A, Moreno-Loscertales C, Marta-Moreno J. Endovascular treatment for acute basilar artery occlusion: descriptive analysis of the experience in a comprehensive stroke centre. Signa Vitae. 2021; 17: 125–131.

[13] Li N, Yang F, Liu D, Guo J, Ge N, Sun S. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway. World Journal of Gastrointestinal Oncology. 2021; 13: 1164–1183.

[14] Ma D, Wu L, Li S, Sun Z, Wang K. Vasohibin2 promotes adriamycin resistance of breast cancer cells through regulating ABCG2 via AKT signaling pathway. Molecular Medicine Reports. 2017; 16: 9729–9734.

[15] Yang Y, Luan Y, Yuan RX, Luan Y. Histone methylation related therapeutic challenge in cardiovascular diseases. Frontiers in Cardiovascular Medicine. 2021; 8: 710053.

[16] Wang L, Cheng L, Ma L, Ahmad Farooqi A, Qiao G, Zhang Y, et al. Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis. Phytotherapy Research. 2022; 36: 525–542.

[17] Redondo A, Gallego A, Mendiola M. Dostarlimab for the treatment of advanced endometrial cancer. Expert Review of Clinical Pharmacology. 2022; 15: 1–9.

[18] Zhang X, Chu C, Ma C, Sun J, Liu Z. Analgesic effect of dizocine combined with ropivacaine on recurrent neuropathic pain in peripheral nerve compression rats. Pharmacology. 2020; 105: 514–521.

[19] Guo Z, Chen P. Physical compatibility and chemical stability of dezocine and ramosetron in 0.9% sodium chloride injection for patient-controlled analgesia administration. Medicine. 2022; 101: e31546.

[20] Huang L, Yan X, Yi M. Hypertensive crisis merging with paroxysmal supraventricular tachycardia after dezocine injection during cesarean delivery: a case report. SAGE Open Medical Case Reports. 2023; 11: 2050313X231160980.